RESUMO
BACKGROUND AND PURPOSE: The histamine H4 receptor, originally thought to signal merely through Gαi proteins, has recently been shown to also recruit and signal via ß-arrestin2. Following the discovery that the reference antagonist indolecarboxamide JNJ 7777120 appears to be a partial agonist in ß-arrestin2 recruitment, we have identified additional biased hH4R ligands that preferentially couple to Gαi or ß-arrestin2 proteins. In this study, we explored ligand and receptor regions that are important for biased hH4R signalling. EXPERIMENTAL APPROACH: We evaluated a series of 48 indolecarboxamides with subtle structural differences for their ability to induce hH4R-mediated Gαi protein signalling or ß-arrestin2 recruitment. Subsequently, a Fingerprints for Ligands and Proteins three-dimensional quantitative structure-activity relationship analysis correlated intrinsic activity values with structural ligand requirements. Moreover, a hH4R homology model was used to identify receptor regions important for biased hH4R signalling. KEY RESULTS: One indolecarboxamide (75) with a nitro substituent on position R7 of the aromatic ring displayed an equal preference for the Gαi and ß-arrestin2 pathway and was classified as unbiased hH4R ligand. The other 47 indolecarboxamides were ß-arrestin2-biased agonists. Intrinsic activities of the unbiased as well as ß-arrestin2-biased indolecarboxamides to induce ß-arrestin2 recruitment could be correlated with different ligand features and hH4R regions. CONCLUSION AND IMPLICATIONS: Small structural modifications resulted in diverse intrinsic activities for unbiased (75) and ß-arrestin2-biased indolecarboxamides. Analysis of ligand and receptor features revealed efficacy hotspots responsible for biased-ß-arrestin2 recruitment. This knowledge is useful for the design of hH4R ligands with biased intrinsic activities and aids our understanding of the mechanism of H4R activation.
Assuntos
Arrestinas/metabolismo , Indóis/farmacologia , Piperazinas/farmacologia , Receptores Acoplados a Proteínas G/efeitos dos fármacos , Receptores Histamínicos/efeitos dos fármacos , Transdução de Sinais/efeitos dos fármacos , Linhagem Celular Tumoral , Desenho de Fármacos , Subunidades alfa Gi-Go de Proteínas de Ligação ao GTP/metabolismo , Células HEK293 , Antagonistas dos Receptores Histamínicos/química , Antagonistas dos Receptores Histamínicos/farmacologia , Humanos , Indóis/química , Ligantes , Modelos Moleculares , Piperazinas/química , Relação Quantitativa Estrutura-Atividade , Receptores Acoplados a Proteínas G/metabolismo , Receptores Histamínicos/metabolismo , Receptores Histamínicos H4 , beta-ArrestinasRESUMO
BACKGROUND AND PURPOSE: The recently proposed binding mode of 2-aminopyrimidines to the human (h) histamine H4 receptor suggests that the 2-amino group of these ligands interacts with glutamic acid residue E182(5.46) in the transmembrane (TM) helix 5 of this receptor. Interestingly, substituents at the 2-position of this pyrimidine are also in close proximity to the cysteine residue C98(3.36) in TM3. We hypothesized that an ethenyl group at this position will form a covalent bond with C98(3.36) by functioning as a Michael acceptor. A covalent pyrimidine analogue will not only prove this proposed binding mode, but will also provide a valuable tool for H4 receptor research. EXPERIMENTAL APPROACH: We designed and synthesized VUF14480, and pharmacologically characterized this compound in hH4 receptor radioligand binding, G protein activation and ß-arrestin2 recruitment experiments. The ability of VUF14480 to act as a covalent binder was assessed both chemically and pharmacologically. KEY RESULTS: VUF14480 was shown to be a partial agonist of hH4 receptor-mediated G protein signalling and ß-arrestin2 recruitment. VUF14480 bound covalently to the hH4 receptor with submicromolar affinity. Serine substitution of C98(3.36) prevented this covalent interaction. CONCLUSION AND IMPLICATIONS: VUF14480 is thought to bind covalently to the hH4 receptor-C98(3.36) residue and partially induce hH4 receptor-mediated G protein activation and ß-arrestin2 recruitment. Moreover, these observations confirm our previously proposed binding mode of 2-aminopyrimidines. VUF14480 will be a useful tool to stabilize the receptor into an active confirmation and further investigate the structure of the active hH4 receptor.
Assuntos
Arrestinas/metabolismo , Agonistas dos Receptores Histamínicos/farmacologia , Pirimidinas/farmacologia , Receptores Acoplados a Proteínas G/agonistas , Compostos de Vinila/farmacologia , Sequência de Aminoácidos , Substituição de Aminoácidos , Desenho de Fármacos , Agonismo Parcial de Drogas , Proteínas de Ligação ao GTP/metabolismo , Células HEK293 , Humanos , Ligantes , Conformação Proteica , Receptores Acoplados a Proteínas G/química , Receptores Acoplados a Proteínas G/metabolismo , Receptores Histamínicos/química , Receptores Histamínicos/metabolismo , Receptores Histamínicos H4 , Transdução de Sinais/efeitos dos fármacos , beta-ArrestinasRESUMO
BACKGROUND: Mood changes have been reported to occur in many women following pregnancy. It is well documented that exercise is associated with reductions in state anxiety and depression. The purpose of this study was to assess mood changes in the postpartum period in women who exercised compared to women who did not exercise. METHODS: All of the women who volunteered for this study had delivered a baby within the past year (mean = 12 wks; SD = 4 wks). Twenty women volunteered to complete the State-Trait Anxiety Inventory and the Profile of Mood States before and following either an exercise session (N = 10) or a quiet rest session (N 10). Exercise consisted of 60 min of low-impact aerobic activity at an intensity between 60-70% of maximal heart rate reserve. Quiet rest consisted of sitting quietly in a room free from distractions for 60 min. Data were analyzed with 2 x 2 ANOVA. RESULTS AND CONCLUSIONS: Results indicated that state anxiety and depression decreased significantly (p < 0.05) following exercise and quiet rest. Furthermore, exercise was associated with significant decreases (p < 0.05) in total mood disturbance, as well as significant increases (p < 0.05) in vigor in physically active postpartum women.